These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


221 related items for PubMed ID: 23834282

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria.
    Takeda K, Imamura Y, Takazono T, Yoshida M, Ide S, Hirano K, Tashiro M, Saijo T, Kosai K, Morinaga Y, Nakamura S, Kurihara S, Tsukamoto M, Miyazaki T, Tashiro T, Kohno S, Yanagihara K, Izumikawa K.
    Med Mycol; 2016 Feb; 54(2):120-7. PubMed ID: 26531100
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of posaconazole for chronic pulmonary aspergillosis.
    Felton TW, Baxter C, Moore CB, Roberts SA, Hope WW, Denning DW.
    Clin Infect Dis; 2010 Dec 15; 51(12):1383-91. PubMed ID: 21054179
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis.
    Bongomin F, Harris C, Hayes G, Kosmidis C, Denning DW.
    PLoS One; 2018 Dec 15; 13(4):e0193732. PubMed ID: 29634721
    [Abstract] [Full Text] [Related]

  • 8. Challenges in the management of chronic pulmonary aspergillosis.
    Kosmidis C, Muldoon EG.
    Med Mycol; 2017 Jan 01; 55(1):63-68. PubMed ID: 27915300
    [Abstract] [Full Text] [Related]

  • 9. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
    Sambatakou H, Dupont B, Lode H, Denning DW.
    Am J Med; 2006 Jun 01; 119(6):527.e17-24. PubMed ID: 16750972
    [Abstract] [Full Text] [Related]

  • 10. Recurrence of chronic pulmonary aspergillosis after discontinuation of maintenance treatment by antifungal triazoles.
    Koyama K, Ohshima N, Suzuki J, Kawashima M, Takeda K, Ando T, Sato R, Nagai H, Matsui H, Ohta K.
    J Infect Chemother; 2014 Jun 01; 20(6):375-9. PubMed ID: 24679654
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of generic forms of itraconazole capsule in treating subjects with chronic pulmonary aspergillosis.
    Sehgal IS, Vinay K, Dhooria S, Muthu V, Prasad KT, Aggarwal AN, Chakrabarti A, Rudramurthy SM, Choudhary H, Agarwal R.
    Mycoses; 2023 Jul 01; 66(7):576-584. PubMed ID: 36967117
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Management of chronic pulmonary aspergillosis.
    Izumikawa K, Tashiro M, Kohno S.
    Ann N Y Acad Sci; 2012 Dec 01; 1272():40-8. PubMed ID: 23231713
    [Abstract] [Full Text] [Related]

  • 15. [Short-term efficacy evaluation of chronic pulmonary aspergillosis treated with micafangin and maintenance therapy of itraconazole].
    Yasuda S, Ohnishi R, Suzuki T, Sano K, Kato T.
    Nihon Kokyuki Gakkai Zasshi; 2009 Nov 01; 47(11):985-90. PubMed ID: 19994592
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.